In 2013 and subsequently, one question in the core of BRFSS asks about vision: Are you blind or do you have serious difficulty seeing, even when wearing glasses? From 2005-2011 the BRFSS employed a ten question vision module regarding vision impairment, access and utilization of eye care, and self-reported eye diseases. The Vision and Eye Health Surveillance System is intended to provide population estimates of vision loss function, eye diseases, health disparities, as well as barriers and facilitators to access to vision and eye care. This information can be used for designing, implementing, and evaluating vision and eye health prevention programs.
The CDC Botulism Consultation Service, the Alaska Division of Public Health, and the California Department of Public Health provide clinical consultations on suspected cases of all types of botulism except infant botulism. These agencies are the only sources of antitoxin for non-infant botulism in the United States. The California Infant Botulism Treatment and Prevention provides clinical consultations on suspected infant botulism cases; it is the only source of antitoxin for infant botulism in the United States. Together, these clinical consultations provide expert guidance to clinicians and support the collection of epidemiologic and medical information for all suspected botulism cases reported in the United States.
Percentages are weighted to population characteristics. Data are not available if it did not meet BRFSS stability requirements.For more information on these requirements, as well as risk factors and calculated variables, see the Technical Documents and Survey Data for a specific year - http://www.cdc.gov/brfss/annual_data/annual_data.htm.Recommended citation: Centers for Disease Control and Prevention (CDC). Behavioral Risk Factor Surveillance System. Atlanta, Georgia: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, [appropriate year].